A case of undifferentiated carcinoma arising from adenomyosis

conference-paper OA: green CC0
AI-generated summary by claude@2026-07+body, 2026-07-09

This case report details an aggressive undifferentiated carcinoma arising from adenomyosis in a 59-year-old woman, which proved fatal seven months post-surgery despite chemotherapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

This paper reports a case of an extremely aggressive undifferentiated carcinoma arising from adenomyosis in a 59-year-old Japanese woman presenting with fatigue, abdominal fullness, and loss of appetite. Diagnostic workup using contrast-enhanced CT and integrated whole-body 18F-fluorodeoxyglucose positron emission tomography/CT identified multiple para-aortic and pelvic lymph node swellings, while contrast-enhanced MRI showed a 3-cm degenerated intramural uterine tumor; the patient underwent total hysterectomy, bilateral salpingo-oophorectomy, para-aortic and pelvic lymphadenectomy, and partial omentectomy. Pathology diagnosed undifferentiated carcinoma arising from adenomyosis, and despite adjuvant chemotherapy, the patient died 7 months after surgery. As an individual case report, it is limited in generalizability, and the authors note that further investigation of similar cases may clarify clinical features. This paper is centrally about adenomyosis — specifically a case of undifferentiated carcinoma arising from adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Malignant transformation of adenomyosis is rare, with endometrioid carcinoma being the most common histological type. Herein, we report the first extremely aggressive case of undifferentiated carcinoma arising from adenomyosis. A 59-year-old Japanese woman was referred to our hospital with complaints of general fatigue, abdominal fullness, and loss of appetite. Contrast-enhanced computed tomography (CT) and integrated whole-body positron emission tomography/CT using 18F-fluorodeoxyglucose revealed multiple para-aortic and pelvic lymph node swellings. Contrast-enhanced magnetic resonance imaging revealed a 3-cm degenerated intramural uterine tumor. The patient underwent total hysterectomy, bilateral salpingo-oophorectomy, para-aortic and pelvic lymphadenectomy, and partial omentectomy for the treatment. Pathologically, the patient was diagnosed with undifferentiated carcinoma arising from adenomyosis. Despite adjuvant chemotherapy, the patient died of the disease 7 months after the initial surgery. Further investigation of similar cases may reveal the clinical features of this disease.
Full text 5,389 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Malignant transformation of adenomyosis is rare, with endometrioid carcinoma being the most common histological type. Herein, we report the first extremely aggressive case of undifferentiated carcinoma arising from adenomyosis. A 59-year-old Japanese woman was referred to our hospital with complaints of general fatigue, abdominal fullness, and loss of appetite. Contrast-enhanced computed tomography (CT) and integrated whole-body positron emission tomography/CT using 18F-fluorodeoxyglucose revealed multiple para-aortic and pelvic lymph node swellings. Contrast-enhanced magnetic resonance imaging revealed a 3-cm degenerated intramural uterine tumor. The patient underwent total hysterectomy, bilateral salpingo-oophorectomy, para-aortic and pelvic lymphadenectomy, and partial omentectomy for the treatment. Pathologically, the patient was diagnosed with undifferentiated carcinoma arising from adenomyosis. Despite adjuvant chemotherapy, the patient died of the disease 7 months after the initial surgery. Further investigation of similar cases may reveal the clinical features of this disease. Similar content being viewed by others Data availability The data are available on the request to the corresponding author.

References

Bulun SE, Yildiz S, Adli M, Wei JJ (2021) Adenomyosis pathogenesis: insights from next-generation sequencing. Hum Reprod Update 27:1086–1097. https://doi.org/10.1093/humupd/dmab017 Koike N, Tsunemi T, Uekuri C, Akasaka J, Ito F, Shigemitsu A et al (2013) Pathogenesis and malignant transformation of adenomyosis (review). Oncol Rep 29:861–867. https://doi.org/10.3892/or.2012.2184 Wang J, Wang Q, Wang W, Yang J, Xia J, Wei Y (2023) Endometrioid adenocarcinoma arising in adenomyosis in a patient with pelvic organ prolapse-case report. BMC Womens Health 23:150. https://doi.org/10.1186/s12905-023-02310-6 Munro MG (2020) Classification and reporting systems for adenomyosis. J Minim Invasive Gynecol 27:296–308. https://doi.org/10.1016/j.jmig.2019.11.013 Sam M, Raubenheimer M, Manolea F, Aguilar H, Mathew RP, Patel VH et al (2020) Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound. Abdom Radiol (NY) 45:842–850. https://doi.org/10.1007/s00261-019-02231-9 Puppa G, Shozu M, Perin T, Nomura K, Gloghini A, Campagnutta E et al (2007) Small primary adenocarcinoma in adenomyosis with nodal metastasis: A case report. BMC Cancer 7:103. https://doi.org/10.1186/1471-2407-7-103 Chao X, Wu M, Ma S, Tan X, Zhong S, Bi Y et al (2020) The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis: A pilot study. Sci Rep 10:5984. https://doi.org/10.1038/s41598-020-63065-w Raffone A, Raimondo D, Maletta M, Travaglino A, Renzulli F, Neola D et al (2023) Endometrial Cancer Arising in Adenomyosis (EC-AIA): A Systematic Review. Cancers (Basel) 15:1142. https://doi.org/10.3390/cancers15041142 Baba A, Yamazoe S, Dogru M, Ogawa M, Takamatsu K, Miyauchi J (2016) Clear cell adenocarcinoma arising from adenomyotic cyst: A case report and literature review. J Obstet Gynaecol Res 42:217–223. https://doi.org/10.1111/jog.12866 Kiuchi K, Hasegawa K, Kanamori A, Machida H, Kojima M, Fukasawa I (2016) Carcinosarcoma arising from uterine adenomyosis: A case report. J Obstet Gynaecol Res 42:358–362. https://doi.org/10.1111/jog.12901 Moraru L, Mitranovici MI, Chiorean DM, Moraru R, Caravia L, Tiron AT et al (2023) Adenomyosis and Its Possible Malignancy: A Review of the Literature. Diagnostics (Basel) 13:1883. https://doi.org/10.3390/diagnostics13111883 Colman HI, Rosenthal AH (1959) Carcinoma developing in areas of adenomyosis. Obstet Gynecol 14:342–348 Machida H, Maeda M, Cahoon SS, Scannell CA, Garcia-Sayre J, Roman LD et al (2017) Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: Are these two different entities? Arch Gynecol Obstet 295:1459–1468. https://doi.org/10.1007/s00404-017-4375-z Talia KL, Naaman Y, McCluggage WG (2021) Uterine adenosarcoma originating in adenomyosis: report of an extremely rare phenomenon and review of published literature. Int J Gynecol Pathol 40:342–348. https://doi.org/10.1097/PGP.0000000000000709 Reinhold C, Tafazoli F, Mehio A, Wang L, Atri M, Siegelman ES et al (1999) Uterine adenomyosis: endovaginal US and MR imaging features with histopathologic correlation. Radiographics 19:S147–S160. https://doi.org/10.1148/radiographics.19.suppl_1.g99oc13s147 Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF et al (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231:372–378. https://doi.org/10.1148/radiol.2312021184

Acknowledgements

We would like to thank Editage (www.editage.jp) for English language editing. Author information Authors and Affiliations Corresponding author Ethics declarations Conflict of interest None declared. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. About this article Cite this article Aoyagi, Y., Nasu, K., Nishida, H. et al. A case of undifferentiated carcinoma arising from adenomyosis. Int Canc Conf J (2026). https://doi.org/10.1007/s13691-026-00874-2 Received: Accepted: Published: Version of record: DOI: https://doi.org/10.1007/s13691-026-00874-2

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

SciLite annotations

chemicals 1
positron

Source provenance

europepmc
last seen: 2026-08-02T06:10:09.037253+00:00
openalex
last seen: 2026-08-02T06:03:29.899990+00:00
pubmed
last seen: 2026-08-02T06:05:02.158895+00:00
scilite
last seen: 2026-07-26T09:53:43.985191+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK